T o date, there is no cure for knee osteoarthritis, and the definitive treatment for this condition is a total knee replacement (TKR). [1] [2] [3] An estimated 4 million United States (US) adults have undergone a TKR; this number represents 4% of adults over the age of 50 years. 4, 5 By 2020, 1.3 million TKRs are projected to be performed annually in the United States. 6, 7 People with knee osteoarthritis participate in low levels of physical activity (PA), 8, 9 which can lead to negative changes in health, including weight gain, lower-body weakness, depressive symptoms, and poor functional ability. [10] [11] [12] Physical inactivity can also increase the risk of preventable medical comorbidities, including diabetes, cardiovascular disease, and premature death. [13] [14] [15] [16] While TKR is successful in relieving pain and restoring function, people remain largely sedentary after TKR. [17] [18] [19] [20] Hence, there is a critical need for a targeted intervention to increase PA in this population. [17] [18] [19] [20] PA tracking devices, such as Fitbit (Fitbit Inc, San Francisco, California), provide a unique opportunity to monitor and promote real-world PA. [21] [22] [23] [24] Steps per day is the most common metric of tracking devices and these devices can accurately estimate daily PA. 24, 25 The primary mode of PA for older adults is walking, making activity tracking devices ideal for this population. 26 In a 2007 systematic review, Bravata et al 23 found pedometers significantly increase PA by roughly 2000 steps per day. These devices are effective because they incorporate multiple behavioral change techniques, such as showing progress toward step goals, self-monitoring, and feedback-thus closely aligning with the social cognitive theory to encourage an increase in PA. 27 The combination of a tracking monitor with guidance to develop a PA plan are key components to promote behavioral change, 28 and have been used previously in clinical trials to increase PA in people with knee osteoarthritis. 28, 29 Pairing of a tracking monitor, goal setting, and feedback from a physical therapist during rehabilitation after TKR could be a low-cost and effective way to increase PA after surgery. Outpatient physical therapy is an ideal, lowcost setting 30, 31 for a PA intervention because physical therapists are experts at prescribing and personalizing exercises to patients and see patients for multiple encounters during an episode of care. 32, 33 These multiple encounters increase the likelihood of changing behavior needed to increase PA, as they allow for the individualized progression of step goals and feedback from the patient. 27 At present, it is unknown whether a physical therapist-administered PA intervention after TKR can increase PA more than standardized physical therapy alone.
The purpose of this article is to present a protocol for a randomized clinical trial to investigate the efficacy, fidelity, and safety of a physical therapist-administered PA intervention for people after TKR.
The primary objective for this trial is to determine the efficacy of a physical therapist-administered PA intervention for people after TKR. Our hypothesis is that people in the intervention group will spend more minutes per week in moderate to vigorous PA (MVPA) than those in the control group at discharge from physical therapy and at 6 months and 12 months after discharge from physical therapy.
Our secondary objective is to evaluate the fidelity and safety of our intervention and investigate changes in self-reported and performance-based physical function. We hypothesize that people in the intervention group will have similar baseline-to-discharge changes in self-reported physical function and objective physical function as the control group.
The exploratory objective is to evaluate the association of psychosocial factors with PA at 6 months and 12 months after discharge from physical therapy. We hypothesize that people with low levels of self-efficacy for exercise and high kinesiophobia will have lower levels of PA. This is a single center, randomized clinical trial comparing standardized physical therapy with a physical therapist-administered PA intervention after unilateral TKR. This study is registered at ClinicalTrials.gov (trial no. NCT03228719). The trial will follow the CONSORT guidelines for participant enrollment and tracking and the TIDieR checklist to describe the intervention (Fig.) .
Methods

Participants
Physical therapists at the Delaware Physical Therapy Clinic at the University of Delaware (UDPT) will recruit participants who are referred to physical therapist for a unilateral TKR. Physical therapists will inform their patient of potential eligibility for our study. If the patient is interested, then a research assistant will determine eligibility, provide pertinent study information, and obtain written informed consent from each participant in person.
Participants who are older than 45 years, have not had or are not planning another lower extremity surgery within 6 months of the study, are seeking outpatient physical therapist services for a unilateral TKR, are interested in increasing their PA, and have not participated in a PA intervention study at UDPT are eligible to participate in this study. Participants are excluded if they have any additional comorbidities that would not allow them to participate in a PA intervention or do not meet the inclusion criteria.
Randomization and Masking
After enrollment in the study, participants are randomized into a control or an intervention group. During the informed consent process, all participants will receive information about the control and intervention group prior to randomization. Participants will not be masked to their group assignments because of the nature of our intervention and the pragmatic design of our trial. A computer randomizer (IBM SPSS Statistics for Windows, v 23 [IBM Corp, Armonk, New York]) will be used to randomize the 125 participants. A research assistant will use the randomizer to assign the participants to a group and provide the participant with study documentation. All other members of the research team will be masked to participants' group assignments. The treating physical therapists, however, will not be masked to the group assignments.
Data Collection and Management
PA data will be collected using an accelerometer for 1 week after enrollment, at discharge from physical therapy, and at 6 months and 12 months after discharge from physical therapy. Research assistants will gather additional demographic, medical, insurance, and clinical data for analysis through medical chart review and will enter data into an electronic database developed by Delaware Rehabilitation Institute and securely stored on a server.
Control Group
Participants in the control group will receive standardized physical therapy provided by a licensed physical therapist at UDPT using the University of Delaware's Rehabilitation Guidelines for Unilateral Total Knee Replacement (eAppendix 1, available at https://academic.oup.com/ptj). Standardized physical therapy also includes a printed home exercise program with an exercise log that is updated weekly by a physical therapist (eAppendix 2).
Intervention
The intervention group will receive a PA intervention in addition to the same standardized physical therapy as the control group. The PA intervention consists of a Fitbit Zip, individualized step goal, and face-to-face feedback provided by a physical therapist.
Fitbit Zip. A research assistant will provide participants in the intervention group with a Fitbit Zip within 1 week after enrolling in the study. They will be asked to wear their Fitbit Zip daily at their right hip during waking hours. They will be asked to remove the device during activities in which the device could get wet (eg, showering, swimming). Participants will be given written and in-person instructions on how to sync their Fitbit Zip to their personal smartphone, tablet, or home computer to track their steps per day.
Individualized step goal. Participants will self-track their steps per day using their Fitbit Zip. The step-perday goal will be based on the data from the Fitbit Zip. They will use their personal electronic device to either show the physical therapist in-person via the Fitbit app or have a written log of their weekly steps per day. When participants are in phase 1 of the UDPT rehabilitation guidelines, 0 to 2 weeks after TKR, they are not expected to increase their PA above 10 minutes per day. Beyond 3 weeks after surgery, phase 2 of the UDPT rehabilitation guidelines, step goals will be initiated and evaluated on a weekly basis. Progression of the weekly step-per-day goal will be a joint decision between the participant and physical therapist. As a guide, the physical therapist will instruct the participant to target a 10% to 20% increase in steps per day until at least 6000 steps per day are achieved. Each week the physical therapist will review the participant's step-per-day goal, and if at least 4 of the 7 previous days per week were at or above the prior week's step-per-day goal, then next week's step-per-day goal will be incrementally increased. This regimen will continue over the course of their rehabilitation, with the end goal of at least 6000 steps per day at discharge from physical therapy. A participant who walks at least 6000 steps per day will be encouraged to continue to increase PA beyond 6000 steps per day without a ceiling threshold because the benefits of PA are not limited but continue in a dose-response fashion.
Face-to-face feedback. The physical therapist will discuss current steps per day with the participant using the Fitbit Zip and set a personalized stepper-day goal each week during their standardized outpatient physical therapy rehabilitation. Physical therapists will encourage participants to meet their step-per-day goal the majority of days during the week while discussing the number of steps per day achieved by the participant. This process will take less than 5 minutes and occur during the participant's physical therapist visit.
Outcome Measures
Primary outcome. Our primary outcome is PA, specifically, minutes per week in MVPA. Increasing MVPA by more than 30 minutes per week is associated with a reduction in risk associated with future mortality and morbidity. 34 Therefore, by using an increase of 30 minutes per week in MVPA as our primary outcome measure, we can capture health gains associated with PA after TKR. We hypothesize that the intervention group will spend 30 minutes more per week in MVPA than the control group at each follow-up time point. We will measure MVPA using an accelerometer, which is a valid and reliable measure of daily PA in older adults. 35 ,36 PA will be measured at 4 time points: baseline, discharge from physical therapy, and 6 months and 12 months after discharge from physical therapy. We will use an Actigraph GT3X (Actigraph, Pensacola, Florida), to measure PA. The participant will be instructed, in person, to wear the monitor around the waist with the accelerometer located at the right hip. A research assistant will instruct participants to put on the monitor when they get up in the morning, take off the monitor when they go to sleep in the evening, and remove the monitor during situations in which the device could get wet (eg, showering, swimming). The Actigraph GT3X will be worn for 1-week bouts at each time point. A masked research assistant will download, screen, and process data from the Actigraph GT3X using a standardized protocol. 36 Specifically, we will include data collected from the monitor when it was worn for more than 4 valid days. A valid day is defined as having more than 10 hours of wear time. 36 Secondary outcome measures. Our secondary outcome measures include intervention fidelity, that is, measuring the adherence of implementing the PA intervention in physical therapist practice. We will check whether physical therapists documented that they reviewed a participant's PA using the Fitbit and whether they reviewed with the participant the individualized step goal in the home exercise program log. Intervention fidelity will be tracked from enrollment to discharge from physical therapy.
The safety of the intervention will be evaluated by measuring adverse events that occur from enrollment to 12 months. An adverse event is defined as any unfavorable or unintended diagnosis, sign, symptom, or disease that is associated with the study and that may or may not be related to the intervention. Preenrollment adverse events will not be included in the safety assessment.
Self-reported physical function will be measured using the Knee Outcome Survey and the Physical Component Summary of the 36-Item Short-Form Survey. The Knee Outcome Survey is a valid and reliable measurement of patient-reported function of the knee, and participants will fill this form out to measure their function after TKR. 37 The Physical Component Summary of the 36-Item Short-Form Survey is routinely used in practice and is a valid and reliable measure of the quality of life after TKR. 38 The objective measure of physical function will be walking endurance on the 6-minute walk test, which is a reliable and valid measure of community ambulation in people with TKR. 39 These measures will be collected via medical chart review by a research assistant. Data will be gathered at the initial physical therapist evaluation and at discharge from physical therapy.
Exploratory outcome measures. The Self-Efficacy for Exercise (SEE) survey and the Fear of Movement Scale for Osteoarthritis (FMSO) questionnaire. The SEE survey is a valid and reliable measure of self-efficacy for exercise in older adults, 40 and the FMSO questionnaire is a valid and reliable measure of fear related to movement in people with osteoarthritis. 41 Both the SEE survey and the FMSO questionnaire will be used at enrollment and at discharge from physical therapy.
Additional data will be collected through the participant's health history: age, sex, body mass index, level of education, household income, marital status, range of motion, knee extension strength, and knee pain on a numerical pain rating scale at best, at worst, and with movement. These data will be used to evaluate for differences between groups at baseline and to adjust the models as needed.
Exit interview. At the 12-month time point, a research assistant will read several scripted exit interview questions to participants on the basis of their group assignments (eAppendix 3, available at https://academic.oup.com/ptj).
Data Analysis, Monitoring, and Auditing
Sample size calculation. Our primary outcome measure is MVPA. We hypothesize that the intervention group will spend 30 minutes per week more in MVPA than the control group, with a standard deviation of 60 minutes per week. In a randomized controlled trial, Bossen et al 42 reported a 24-minute difference in MVPA at 12 months between the groups. We used this change in MVPA as a basis for our hypothesis. We will need a sample size of 125 to achieve 5% of a type I error and 80% power to reach statistical significance, assuming a 20% dropout rate. In addition, we will use an alpha level of .05 and a 2-tailed test in order to determine a difference between groups for MVPA. Statistical analysis. We will describe primary, secondary, and outcome measures for both the intervention and control groups using means and standard deviations for continuous measures and frequencies for categorical measures. To ensure groups are equal at baseline, we will compare demographics and participant characteristics at enrollment using an analysis of variance or chisquared test. If the groups are different at baseline, then we will adjust for the variables in a multivariate model. For missing baseline data, we will conduct a complete analysis with an alpha level set at .05.
To determine the efficacy of the intervention and which group spent more minutes per week in MVPA, we will use a 2-way mixed-design analysis of variance and compare PA at discharge from physical therapy and PA at 6 months and 12 months after discharge from physical therapy. We will analyze the data using an unadjusted and adjusted multiple regression model, adjusting for potential confounders including age, sex, body mass index, education, comorbidity, knee pain intensity, and depressive symptoms. Analyses will be run twice, first using a per-protocol analysis that tests the data for all those who completed all sessions. Second, we will evaluate whether the added component (addition of the intervention) affected results by running the analysis again using an intention-to-treat approach with a last-value-carried-forward method. If dropouts exceed the expected 20%, then analysis will be done using a general linear mixed-methods model.
To analyze the secondary outcomes, fidelity, and safety of the intervention, we will describe in terms of frequencies (ie, the percentage of physical therapist appointments that included both review of the participant's PA and review of the individualized step goal from the electronic medical record). We will report the mean and standard deviation of the occurrences. Adverse events will also be reported in a similar manner. Finally, to explore the association of self-efficacy for exercise and kinesiophobia with the intervention, we will calculate the effect estimates from a linear model with interaction by group assignment and adjust for the same potential confounders.
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Discussion
Our project is important because we are investigating a physical therapistadministered PA intervention in a population prone to persistent inactivity. If the results from this study demonstrate efficacy, as defined by the intervention group spending more time in MVPA, as well as fidelity and safety of the intervention, then we will proceed to a large multisite trial. This intervention is important because it has the potential to increase PA and mitigate future disability in people after TKR.
Strengths and Weaknesses
The strength of our study is that it is a randomized controlled trial, powered to determine the efficacy of a physical therapist-administered PA intervention. In addition, the intervention is pragmatic and physical therapists have the ability to make a patient-centered clinical decision to develop and progress the activity intervention.
A weakness of our study is that participants will not be masked to their group assignments because of our pragmatic trial design and the type of PA intervention that we used. Another limitation of our study is that PA data collection happens after randomization. The study is taking place in a clinical setting, and, for logistical purposes, we are unable to collect PA data before randomization. We did not exclude participants who currently use or plan on using a PA monitor during their outpatient physical therapy after TKR. This could result in contamination of the control-for example, participants in the control group using an activity monitor. Since the control group will not receive the step goals, we believe there will be minimal to no effect of contamination on our study outcome. Single-site for our trial is also a weakness, since it may limit generalizability to other clinics.
Contribution to the Physical Therapist Profession
Pending the results of our study, we aim to change physical therapist clinical practice by targeting PA as a part of routine treatment after TKR. Traditionally, physical therapy after TKR addresses impairments and functional limitations-such as pain or the ability to rise from a chair-with little attention related to PA. During outpatient physical therapy, there is a teachable
